RDL GOLD

Used In Secondary Prevention of High Risk Patients

Rosuvastatin: Potent LDL-C reduction, plaque stabilization, anti-inflammatory and endothelial protective effects.

DAPT: Blocks platelet aggregation via two pathways (Aspirin – COX-1 inhibition; P2Y12 inhibitor – ADP receptor blockade), preventing thrombosis and stent occlusion.

Description

Rosuvastatin 10mg/20mg+ Clopidogrel 75mg+ ASA 75mg

Used In Secondary Prevention of High Risk Patients

Together, they address lipid-driven atherosclerosis + thrombotic risk.

Dosage: Available in oral Capsule form. Once Daily